Amplia Therapeutics Ltd's latest results suggest candidate improves survival in human pancreatic cancer model
Amplia Therapeutics Ltd (ASX:ATX) says researchers at the Garvan Institute have shown that drug candidate AMP945 is able to improve the effectiveness of a...